These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6722771)

  • 1. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice.
    Swaminathan S; Bryan GT
    Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
    Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB
    Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity, carcinogenicity, distribution, and nitroreduction of 4-(5-nitro-2-furyl)thiazole in the rat.
    Swaminathan S; Ertürk E; Bryan GT
    Cancer Res; 1981 Jul; 41(7):2648-53. PubMed ID: 7018666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioconversion and macromolecular binding of 2-amino-4-(5-nitro-2-furyl)thiazole by cultured rat urothelial cells.
    Swaminathan S; Johnson MD; Reznikoff CA; Bryan GT
    Cancer Res; 1984 Dec; 44(12 Pt 1):5511-6. PubMed ID: 6498813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR; Spry LA; Zenser TV; Davis BB
    Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and excretion of nitrofurothiazole bladder carcinogens.
    Spry L; Lakshmi VM; Zenser T; Davis B
    J Pharmacol Exp Ther; 1986 Aug; 238(2):457-62. PubMed ID: 3735127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
    Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB
    J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of urine of various species fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or 2-amino-4-(5-nitro-2-furyl)thiazole.
    Hayashida S; Wang CY
    Mutat Res; 1984 Mar; 135(3):169-73. PubMed ID: 6369128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced macromolecular binding of N-[4-(5-nitro-2-furyl)-2-thiazolyl]- formamide in germfree versus conventional rats.
    Morton KC; Wang CY
    Cancer Res; 1983 Aug; 43(8):3628-32. PubMed ID: 6190554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
    Spry LA; Zenser TV; Cohen SM; Davis BB
    J Clin Invest; 1985 Sep; 76(3):1025-31. PubMed ID: 4044826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early induction of mouse urinary bladder ornithine decarboxylase activity by rodent vesical carcinogens.
    Matsushima M; Bryan GT
    Cancer Res; 1980 Jun; 40(6):1897-901. PubMed ID: 7371022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaerobic metabolism and nuclear binding of the carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT).
    Mattammal MB; Zenser TV; Davis BB
    Carcinogenesis; 1982; 3(11):1339-44. PubMed ID: 6817938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for detection and analysis of carcinogenic nitrofuran compounds and their metabolites by combining chromatography and spot mutation tests.
    Hayashida S; Wang CY; Bryan GT
    Gan; 1976 Aug; 67(4):617-9. PubMed ID: 799604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
    Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
    Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase.
    Zenser TV; Mattammal MB; Davis BB
    Cancer Res; 1980 Jan; 40(1):114-8. PubMed ID: 6765914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 4-(5-amino-2-furyl)thiazole (AFT) as a reductive metabolite of the carcinogen 4-(5-nitro-2-furyl)thiazole (NFT).
    Swaminathan S; Ichikawa M; Bryan GT
    Carcinogenesis; 1986 Apr; 7(4):615-9. PubMed ID: 3698193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of aromatic and heterocyclic amine bladder carcinogens: bioanalytical considerations.
    Mattammal MB; Lakshmi VM; Zenser TV; Davis BB
    J Pharm Biomed Anal; 1990; 8(2):151-8. PubMed ID: 2128813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxidase metabolism of the urinary bladder carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole.
    Wise RW; Zenser TV; Davis BB
    Cancer Res; 1983 Apr; 43(4):1518-22. PubMed ID: 6403225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.